Evert B. Schimmelpennink insider trades

Open-market stock purchases and sales by Evert B. Schimmelpennink, Director at Contineum Therapeutics, Inc, from SEC Form 4 filings since Sep 1, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -29%.

Recent trades

DateStockTradeValue
Jun 26, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Mar 27, 2026LENZ LENZ Therapeutics, IncBought$251K
Jan 2, 2026LENZ LENZ Therapeutics, IncBought (not open market)—
Nov 20, 2025IBIO iBio, IncBought (not open market)—

Companies traded

  • CTNM Contineum Therapeutics, Inc: other filings, last Jun 26, 2026
  • LENZ LENZ Therapeutics, Inc: 1 buy, last Mar 27, 2026
  • IBIO iBio, Inc: other filings, last Nov 20, 2025
  • PFNX Pfenex Inc: 2 buys, last Oct 1, 2020

Get free alerts when Evert B. Schimmelpennink files a new trade →